Research Topic

Heart and Vascular Hemodynamic in Processes of Neurodegeneration

About this Research Topic

Neurodegenerative diseases are among the main chronic illnesses and the first cause of mortality and disability worldwide. They include a spectrum of clinical disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD), Cerebrovascular disease (CeVD), Huntington disease (HD), and Vascular Dementia ...

Neurodegenerative diseases are among the main chronic illnesses and the first cause of mortality and disability worldwide. They include a spectrum of clinical disorders, such as Alzheimer's disease (AD), Parkinson's disease (PD), Cerebrovascular disease (CeVD), Huntington disease (HD), and Vascular Dementia (VD), among others.

Despite a great scientific effort to improve pharmacological treatment and prevention, an effective therapy against neurodegenerative diseases has not been discovered so far.

The principal mechanism leading to all neurodegenerative diseases is neurodegeneration, defined as a progressive and inexorable death of neurons and loss in neuronal function. Neurodegeneration may be induced by complex and multifactorial processes, which usually are a combination of vascular, environmental and genetic factors.

Hopefully, a better understanding of the biology of neurodegeneration and the interactions between the factors leading to it, may allow to develop novel and more efficient pharmacotherapies.

Strong evidence suggests that changes in the heart, peripheral and cerebral blood flow hemodynamic have a functional role in the development of neurodegenerative and cognitive diseases.

Alterations in cerebral blood flow (CBF) due to change in large cerebral blood vessels, such as carotid arteries, have been associated with an increase in the risk for cognitive decline and AD. Different phenotypes of carotid atherosclerosis, like carotid intima media thickness (IMT) and carotid stiffness, have been linked with major markers of neurodegeneration, such as white matter hyperintensities (WMH) and amyloid-β peptide accumulation.

Heart failure, by controlling the CBF directly, has been demonstrated to be correlated with risk for cognitive decline. Impairment in heart function (e.g. chronic arrhythmia) along with increase in vascular peripheral resistance further promote the disruption of cerebral microvessels and formation of microemboli.

Several have been the proposed mediators underlying the association between impairment in vascular homeostasis and neurodegeneration, including endothelial factors, nitric oxide (NO), mitochondrial respiration, oxidative stress and inflammation.

Based on these previous evidences, therapies for vascular disease cure and prevention, as statins, antihypertensive, and antidiabetic drugs, have been already proposed and tested as candidates to treat neurodegenerative diseases - especially drugs related to specific molecular pathways discusses above. However, so far, the neurodegenerative diseases are incurable. The investigation of pathological processes linking CBF with progression of neurodegeneration and cognitive decline may be an opportunity for drug repurposing (also known as drug repositioning or drug reprofiling) and to discovery novel therapies targeting both vascular and neurodegenerative diseases.

This Research Topic will focus on providing an overview in the current knowledge on the mechanisms underlying the link between central and peripheral blood flow hemodynamic and neurodegeneration, with the special emphasis on the current and most promising therapies in this field.

Possible studies discussing vascular and environmental risk factors, genetic variants, and molecular pathways implicated in this association, along with discussion on drugs or compounds affecting them, are welcome. We also welcome Original Research papers, Review articles and brief communications addressing the same field.


Keywords: Blood Flow, Heart Failure, Cerebrovascular Homeostasis, Neurodegeneration, Atherosclerosis


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Recent Articles

Loading..

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

20 October 2019 Manuscript
19 November 2019 Manuscript Extension

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

20 October 2019 Manuscript
19 November 2019 Manuscript Extension

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..

Comments

Loading..

Add a comment

Add comment
Back to top